Name: Bismuth potassium citrate | Bismuth tripotassium dicitrate; Bismuth subcitrate
Brand: Ambeed
SKU: A126800
Rating: 4.1 (136 reviews)

CAS No. :	57644-54-9
Formula :	C₁₂H₁₀BiK₃O₁₄
M.W :	704.47
SMILES Code :	O=C(CC(C([O-])=O)(O)CC([O-])=O)[O-].O=C(CC(C([O-])=O)(O)CC([O-])=O)[O-].[Bi+3].[K+].[K+].[K+]
Synonyms :	Bismuth tripotassium dicitrate; Bismuth subcitrate; De-Nol
MDL No. :	MFCD02101411

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

NCT01209455	Poisoning	Not Applicable	Unknown	September 2012	United Kingdom ... More >> Clinical Research Facility, Royal Infirmary of Edinburgh Recruiting Edinburgh, Midlothian, United Kingdom, EH16 4SA Principal Investigator: Euan A Sandilands, MRCP BSc Less <<
NCT02703896	Pulmonary Aspiration of Gastri... More >>c Contents Less <<	Phase 4	Completed	-	-
NCT00223691	Autonomic Failure ... More >> Orthostatic Hypotension Less <<	Phase 1	Completed	-	United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT02441673	Post Anaesthetic Shivering	Phase 2	Not yet recruiting	June 2019	-
NCT00930670	Coronary Artery Disease	Phase 4	Completed	-	Canada, Quebec ... More >> Institut Universitaire de Cardiologie et de Pneumologie de Quebec Quebec City, Quebec, Canada, G1V4G5 Less <<
NCT02953210	Pain, Postoperative ... More >> Anesthesia Complication Nausea Vomiting Ileus Paralytic Hemodynamic Instability Less <<	Phase 4	Unknown	March 2017	Brazil ... More >> Faculdade de Ciências Médicas da Santa Casa de São Paulo Sao Paulo, Brazil, 01221-020 Faculdade de Ciências Médicas da Santa Casa de São Paulo Sao Paulo, Brazil, 01333000 Less <<
NCT01332630	-		Completed	-	-
NCT02169856	Postoperative Nausea and Vomit... More >>ing Less <<	Not Applicable	Completed	-	Pakistan ... More >> Benazir Bhutto Hospital Rawalpindi. Rawalpindi, Punjab, Pakistan, 46000 Less <<
NCT02966665	Chronic Obstructive Pulmonary ... More >>Disease Pulmonary Artery Hypertension Heart Failure Hypertension Less <<	Phase 1	Recruiting	August 2020	United States, Utah ... More >> George E Wahlen VA Medical Center Recruiting Salt Lake City, Utah, United States, 84132 Contact: Russell Richardson, Ph.D. 801-582-1565 r.richardson@hsc.utah.edu Contact: Ashley Nelson, MD 801-582-1565 ext 4127 ash.nelson@hsc.utah.edu Less <<
NCT02441894	Prostate Cancer	Phase 4	Completed	-	Japan ... More >> Investigational Site Number 392004 Chuo-ku, Chiba, Japan Investigational Site Number 392008 Kita-gun, Japan Investigational Site Number 392007 Kobe-shi, Hyogo, Japan Investigational Site Number 392005 Nagakute-shi, Aichi, Japan Investigational Site Number 392006 Osaka Sayama-shi, Osaka, Japan Investigational Site Number 392001 Shinjuku-ku, Tokyo, Japan Investigational Site Number 392002 Yokohama-shi, Kanagawa, Japan Investigational Site Number 392009 Yokohama-shi, Japan Less <<
NCT01261546	Parapneumonic Pleural Effusion... More >> Empyema Less <<	Phase 2	Completed	-	Spain ... More >> Hospital Carlos Haya Malaga, Andalucia, Spain Complejo Hospitalario Toledo Toledo, Castilla La Mancha, Spain Hospital Principe de Asturias Alcalá de Henares, Madrid, Spain Hospital Universitario de Getafe Getafe, Madrid, Spain Hospital Infanta Sofia San Sebastián de los Reyes, Madrid, Spain, 28014 Hospital Infantil La Paz Madrid, Spain, 28037 Hospital Ramón y Cajal Madrid, Spain Hospital Universitario Gregorio Marañón Madrid, Spain Less <<
NCT01896557	Coronary Artery Disease ... More >> Drug Interaction Potentiation Less <<	Phase 4	Completed	-	-
NCT02999633	T-cell Type Acute Leukemia-Pre... More >>cursor T-lymphoblastic Lymphoma/Leukaemia Less <<	Phase 2	Terminated(Due to an unsatisfa... More >>ctory benefit/risk ratio, as specified in & 14.8.1 of the protocol, Sanofi decided to stop enrollment and terminate ACT14596 prematurely) Less <<	-	United States, Georgia ... More >> Investigational Site Number 8400002 Atlanta, Georgia, United States, 30342 United States, New Jersey Investigational Site Number 8400003 Hackensack, New Jersey, United States, 07601 United States, Texas Investigational Site Number 8400001 Houston, Texas, United States, 77030 Finland Investigational Site Number 2460001 Helsinki, Finland, 00029 France Investigational Site Number 2500005 Nantes Cedex 01, France, 44093 Investigational Site Number 2500001 Paris Cedex 10, France, 75475 Investigational Site Number 2500004 Pessac, France, 33600 Investigational Site Number 2500002 Pierre Benite, France, 69310 Hungary Investigational Site Number 3480001 Budapest, Hungary, 1083 Investigational Site Number 3480003 Budapest, Hungary, 1097 Investigational Site Number 3480002 Debrecen, Hungary, 4032 Italy Investigational Site Number 3800001 Bergamo, Italy, 24127 Investigational Site Number 3800004 Brescia, Italy, 25123 Lithuania Investigational Site Number 4400001 Vilnius, Lithuania, 08661 Russian Federation Investigational Site Number 6430003 Moscow, Russian Federation, 117198 Investigational Site Number 6430004 Moscow, Russian Federation, 125167 Investigational Site Number 6430001 Moscow, Russian Federation, 129301 Less <<
NCT01896557	-		Completed	-	-
NCT01332630	Breast Cancer	Phase 2	Completed	-	United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00000964	HIV Infections	Phase 1	Completed	-	United States, Maryland ... More >> Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States, 21205 Less <<
NCT01392755	Healthy Volunteer	Phase 1	Completed	-	United States, Kansas ... More >> Lenexa, Kansas, United States, 66219 Less <<
NCT02123498	Eustachian Tube Dysfunction ... More >> Laryngopharyngeal Reflux Less <<	Phase 4	Withdrawn(IRB not approved)	-	United States, California ... More >> 11234 Anderson Street Loma Linda, California, United States, 92354 1895 Orange Tree Lane, Suite 102 Redlands, California, United States, 92374 Less <<
NCT01976078	-		Completed	-	United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT03583567	Protamine Adverse Reaction	Phase 4	Recruiting	December 1, 2020	Thailand ... More >> Siriraj Hospital Recruiting Bangkok, Thailand, 10700 Contact: Sirilak Suksompoong, MD ssuksompong5@gmail.com Less <<
NCT03145012	Cancer	Phase 4	Not yet recruiting	April 30, 2019	Canada, Nova Scotia ... More >> Nova Scotia Health Authority Not yet recruiting Halifax, Nova Scotia, Canada, B3H 1V7 Contact: Lisa Barrett, MD lisa.barrett@nshealth.ca Contact: Jill Moore jill.moore@nshealth.ca Less <<
NCT00405119	Gastroesophageal Reflux Diseas... More >>e Reflux, Gastroesophageal Less <<	Phase 2	Completed	-	Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Herston, Queensland, Australia, 4006 Less <<
NCT02172417	Healthy	Phase 1	Completed	-	-
NCT02373280	Helicobacter Infection	Not Applicable	Recruiting	December 2019	Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Contact: Nayoung Kim, M.D, Ph.D +82-31-787-7008 nayoungkim49@empas.com Less <<
NCT00401752	Gastric Ulcer	Phase 3	Completed	-	China, Fujian ... More >> Research Site Fuzhou, Fujian, China China, Guangdong Research Site Guangzhou, Guangdong, China China, Hubei Research Site Wuhan, Hubei, China China, Jiangsu Research Site Suzhou, Jiangsu, China China, Liaoning Research Site Shenyang, Liaoning, China China, Shanxi Research Site Xi'an, Shanxi, China China Research Site Beijing, China Research Site Shanghai, China Hong Kong Research Site Hong Kong, Hong Kong Less <<
NCT03011463	Pharmacokinetics ... More >> Inhibition Enzyme Drug Interaction Potentiation Less <<	Phase 1	Completed	-	-
NCT03468777	Healthy	Phase 1	Terminated(The study has been ... More >>terminated due to pending data analysis) Less <<	-	Belgium ... More >> Clinical Pharmacology Unit Merksem, Belgium, 2170 Less <<
NCT00247130	Peptic Ulcers	Phase 4	Withdrawn(Superiority of iv om... More >>eprazole to ranitidine has already been proven by others.) Less <<	-	Japan ... More >> Department of Internal Medicine, Keio University School of Medicine Tokyo, Japan, 1608582 Less <<
NCT00633412	NSAID Associated Gastric Ulcer... More >>s Less <<	Phase 3	Completed	-	-
NCT00590928	Critically Ill Patients ... More >> Indication for Stress Ulcer Prophylaxis Less <<	Phase 4	Completed	-	Austria ... More >> Medical University of Vienna, Department of Medicine III, ICU Vienna, Austria, 1090 Less <<
NCT00633672	NSAID Associated Gastric Ulcer... More >>s Less <<	Phase 3	Completed	-	-
NCT00401752	-		Completed	-	-
NCT00668317	Cough	Phase 3	Terminated(Primary care physic... More >>ians began prescribing antacid therapy for chronic cough) Less <<	-	United Kingdom ... More >> Clinical Trials Unit , Cardiovascular and respiratory studies, Castle Hill Hospital Cottingham, East Yorkshire, United Kingdom, HU16 5JQ Less <<
NCT00668317	-		Terminated(Primary care physic... More >>ians began prescribing antacid therapy for chronic cough) Less <<	-	-
NCT00838526	Gastroesophageal Reflux Diseas... More >>e (GERD) Less <<	Phase 3	Completed	-	United States, Illinois ... More >> Ltd. Moline, Illinois, United States, 61265 Midwest Clinical Moline, Illinois, United States, 61265 Research Associates Moline, Illinois, United States, 61265 Moline, Illinois, United States, 61265 Less <<
NCT00839306	-		Completed	-	-
NCT00131248	Gastroesophageal Reflux	Phase 3	Completed	-	United States, Texas ... More >> Memorial Hermann Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00131248	-		Completed	-	-
NCT03365609	Helicobacter Infections	Not Applicable	Recruiting	December 31, 2018	China, Shanghai ... More >> Children's hospital of Fudan university Recruiting Shanghai, Shanghai, China, 201102 Contact: Ying Huang, MD and PhD 13816882247 yhuang815@163.com Sub-Investigator: Ying Zhou Less <<
NCT01682408	Pharmacokinetics	Phase 1	Completed	-	United States, Kansas ... More >> Overland Park, Kansas, United States Less <<

{[proInfo.proName]}

CAS No.: 57644-54-9

{[proInfo.proName]}

CAS No.: 57644-54-9

Alternative Products

Product Details of Bismuth potassium citrate

Safety of Bismuth potassium citrate

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator